American Association for Cancer Research

AACR Cancer Policy Monitor

Bookmark and Share
CPM
December 2011

 


 

CONGRESS REACHES FY2012 SPENDING COMPROMISE

In otherwise bleak budget year, NIH and NCI to receive increased funds

After months of debate and facing another possibility of a government shutdown, Congress reached a last-minute compromise on fiscal year 2012 spending priorities, including funding for the National Institutes of Health (NIH) and the National Cancer Institute (NCI). Read more

 


 

2011 IN REVIEW

A review of this year’s biggest stories for cancer research and their implications for 2012

Take a look back at the events that shaped 2011 and read predictions for what to expect in 2012. Read more

 


 

VARMUS UPDATES CANCER ADVISORY BOARD                                                   

 Director anticipates contentious budget year in FY2013

While addressing the NCI National Cancer Advisory Board on Dec. 6, the institute’s director, Harold Varmus, M.D., told board members to brace for a contentious budget year in fiscal year 2013, but added that the institute has at hand the resources to do “some important things” to make continued progress against cancer. Read more

 


 

AACR CONVENES DISCUSSION ABOUT CANCER DRUG DEVELOPMENT          

AACR Task Force to spearhead further opportunities to examine policy issues facing cancer researchers and regulators

During an AACR scientific conference last month, representatives from European and U.S. regulatory bodies joined scientists from academia and industry to discuss the challenges facing rational cancer drug development for targeted drugs. Read more

 


 

Top